298
Views
0
CrossRef citations to date
0
Altmetric
Review

Acceptability and determinants of using male hormonal contraceptives: a systematic review from a gender perspective

ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 689-719 | Received 08 Feb 2022, Accepted 03 Mar 2023, Published online: 28 Mar 2023

References

  • Agnew, C. R., Harvey, S. M., Vanderdrift, L. E., Warren, J., & Author, H. P. (2017). Relational underpinnings of condom use: Findings from the project on partner dynamics HHS public access author manuscript. Health Psychology, 36(7), 713–720. https://doi.org/10.1037/hea0000488
  • Amory, J. K., Page, S. T., Anawalt, B. D., Matsumoto, A. M., & Bremner, W. J. (2007). Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen. Contraception, 75(3), 218–223. https://doi.org/10.1016/j.contraception.2006.11.003
  • Anderson, R. A., & Baird, D. T. (2002). Male contraception. Endocrine Reviews, 23(6), 735–762. https://doi.org/10.1210/er.2002-0002
  • Balswick, J. O. (1972). Attitudes of lower class males toward taking a male birth control pill. Family Coordinator, 21(2), 195–199. https://doi.org/10.2307/582394
  • Behre, H. M., Zitzmann, M., Anderson, R. A., Handelsman, D. J., Lestari, S. W., & McLachlan, R. I. (2016). Efficacy and safety of an injectable combination hormonal contraceptive for men. The Journal of Clinical Endocrinology and Metabolism, 101(12), 4779–4788. https://doi.org/10.1210/jc.2016-2141
  • Brady, B. M., Amory, J. K., Perheentupa, A., Zitzmann, M., Hay, C. J., & Apter, D. (2006). A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive. Human Reproduction (Oxford, England), 21(1), 285–294. https://doi.org/10.1093/humrep/dei300
  • Brooks, M. (1998). Men’s views on male hormonal contraception – a survey of the views of attenders at a fitness centre in Bristol, UK. The British Journal of Family Planning, 24(1), 7–17.
  • Bustamante-Forest, R., & Giarratano, G. (2004). Changing men’s involvement in reproductive health and family planning. The Nursing Clinics of North America, 39, 301–318. https://doi.org/10.1016/j.cnur.2004.02.001
  • Campo-Engelstein, L. (2012). Contraceptive Justice: Why we need a male pill. The Virtual Mentor: VM, 14(2), 146–151. https://doi.org/10.1001/virtualmentor.2012.14.2.msoc1-1202
  • CASP. NHS Critical Appraisal Skills Programme (CASP): Appraisal tools [Internet]. NHS PublicHealth Resource Unit. 2017 [cited. 2020 Apr 19]. Available from: https://casp-uk.net/wp-content/uploads/2018/01/CASP-Qualitative-Checklist-2018.pdf
  • CIHR. (2014). What is gender? What is sex?. http://www.cihr-irsc.gc.ca/e/48642.html
  • Cochrane. (2014). ERC data collection form for intervention reviews for RCTs and non-RCTs. https://community.cochrane.org/sites/default/files/uploads/inline-files/ERC%20data%20collection%20form%20for%20intervention%20reviews%20for%20RCTs%20and%20non-RCTs.doc
  • Contraception | Reproductive Health | CDC [Internet]. [cited. 2021 Jan 11]. Available from: https://www.cdc.gov/reproductivehealth/contraception/index.htm
  • Dismore, L., Van Wersch, A., & Swainston, K. (2014). Social constructions of the male contraception pill: When are we going to break the vicious circle? Journal of Health Psychology, 21(5), 788–797. https://doi.org/10.1177/1359105314539528
  • Eberhardt, J., Van Wersch, A., & Meikle, N. (2009). Attitudes towards the male contraceptive pill in men and women in casual and stable sexual relationships. Journal of Family Planning and Reproductive Health Care, 35(3), 161–165. https://doi.org/10.1783/147118909788707986
  • Frankiewicz, M., Połom, W., & Matuszewski, M. (2018). Can the evolution of male contraception lead to a revolution? Review of the current state of knowledge. Central European Journal of Urology, 71(1), 108–113. https://doi.org/10.5173/ceju.2017.1450
  • Gava, G., & Meriggiola, M. C. (2019). Update on male hormonal contraception. Therapeutic Advances in Endocrinology and Metabolism, 10, 1–9. https://doi.org/10.1177/2042018819834846
  • Glasier, A. Acceptability of contraception for men: A review. Contraception [Internet]. 2010 Nov 1 [cited. 2019 May 17];82(5):453–456. https://doi.org/10.1016/j.contraception.2010.03.016.
  • Glasier, R., Anakwe, D., Everington, C. W., Martin, Z., Van Der Spuy, L., & Cheng, P. C. (2000). Would women trust their partners to use a male pill? Human Reproduction (Oxford, England), 15(3), 646–649. https://doi.org/10.1093/humrep/15.3.646
  • Gómez-Torres, P., Lucha-López, A. C., Martínez-Pérez, G. Z., Sheridan, T., Vera Cruz, G. Analysis of acceptability studies of the male hormonal contraceptives: A systematic review [Internet]. PROSPERO. 2020 [cited. 2020 Oct 24]. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=210015
  • Gough, H. (1979). Some factors related to men’s stated willingness to use a male contraceptive pill. Journal of Sex Research, 15(1), 27–37. https://doi.org/10.1080/00224497909551021
  • Hay, C. J., Brady, B. M., Zitzmann, M., Osmanagaoglu, K., Pollanen, P., & Apter, D. (2005). A multicenter phase IIb study of a novel combination of intramuscular androgen (testosterone decanoate) and oral progestogen (etonogestrel) for male hormonal contraception. The Journal of Clinical Endocrinology and Metabolism, 90(4), 2042–2049. https://doi.org/10.1210/jc.2004-0895
  • Heinemann, K., Saad, F., Wiesemes, M., White, S., & Heinemann, L. (2005). Attitudes toward male fertility control: Results of a multinational survey on four continents. Human Reproduction (Oxford, England), 20(2), 549–556. https://doi.org/10.1093/humrep/deh574
  • Higgins, J. P. T., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K.F., Weeks, L., Sterne, J.A.C., Cochrane Bias Methods Group & Cochrane Statistical Methods Group, (2011). The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Clinical Research Ed.), 343, d5928. https://doi.org/10.1136/bmj.d5928
  • Ilani, N., Roth, M. Y., Amory, J. K., Swerdloff, R. S., Dart, C., & Page, S. T. (2012). A new combination of testosterone and nestorone transdermal gels for male hormonal contraception. The Journal of Clinical Endocrinology and Metabolism, 97(10), 3476–3486. https://doi.org/10.1210/jc.2012-1384
  • Jaccard, J., Hand, D., Ku, L., & Ar, R. K. (1981). Attitudes toward male oral contraceptives: Implications for models of the relationship between beliefs and attitudes. Journal of Applied Social Psychology, 11(3), 181–191. https://doi.org/10.1111/j.1559-1816.1981.tb00737.x
  • Keith, L., Keith, D., & Wj, B. R. (1975). Attitudes of men toward contraception. Archives of Gynecology, 220, 89–07. https://doi.org/10.1007/BF00667114
  • Laird, J. (1994). A male pill? Gender discrepancies in contraceptive commitment. Feminism and Psychology, 4(3), 458–468. https://doi.org/10.1177/0959353594043018
  • Liu, P. Y., Swerdloff, R. S., & Wang, C. (2010). Recent methodological advances in male hormonal contraception. Contraception, 82(5), 471–475. https://doi.org/10.1016/j.contraception.2010.03.010
  • Marcell, A. V., Plowden, K., & Bowman, S. M. (2005). Exploring older adolescents’ and young adults’ attitudes regarding male hormonal contraception: Applications for clinical practice. Human Reproduction (Oxford, England), 20(11), 3078–3084. https://doi.org/10.1093/humrep/dei168
  • Marsiglio, W. (1985). Husbands’ sex-role preferences and contraceptive intentions: The case of the male pill. Sex Roles, 12(5–6), 655–663. https://doi.org/10.1007/BF00288184
  • Martin, C. W., Anderson, R. A., Cheng, L., Ho, P. C., van der Spuy, Z., Smith, K. B., Glasier, A.F., Everington, D., Baird, D.T. (2000). Potential impact of hormonal male contraception: Cross-cultural implications for development of novel preparations. Human Reproduction (Oxford, England), 15(3), 637–645. https://doi.org/10.1093/humrep/15.3.637
  • Meriggiola, M. C., Cerpolini, S., Bremner, W. J., Mbizvo, M. T., Vogelsong, K. M., & Martorana, G. (2006). Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men. Human Reproduction (Oxford, England), 21(8), 2033–2040. https://doi.org/10.1093/humrep/del094
  • Moher, D. PRISMA 2009 Checklist. PLoS Med [Internet].2009 [cited. 2020 Jan 4];6(6):e1000097. Available from: http://prisma-statement.org/documents/PRISMA2009checklist.pdf
  • NICHD. (2018). Study of spermatogenesis suppression with DMAU alone or with LNG versus placebo alone in normal men. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03455075
  • Nieschlag, E. (2010). Clinical trials in male hormonal contraception. Contraception, 82(5), 457–470. https://doi.org/10.1016/j.contraception.2010.03.020
  • O’Connor, D. B., Ferguson, E., & O’Connor, R. C. (2005). Intentions to use hormonal male contraception: The role of message framing, attitudes and stress appraisals. British Journal of Health Psychology, 96(3), 351–369. https://doi.org/10.1348/000712605X49114
  • Oudshoorn, N. (2003). The male pill: A biography of a technology in the making. Duke University Press.
  • Peterson, L. M., Campbell, M. A. T., & Laky, Z. E. (2019). The next frontier for men’s contraceptive choice: College men’s willingness to pursue male hormonal contraception. Psychology of Men and Masculinity, 20(2), 226–237. https://doi.org/10.1037/men0000174
  • Pöllänen, P., Nikkanen, V., & Huhtaniemi, I. (2001). Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception. International Journal of Andrology, 24(6), 369–380. https://doi.org/10.1046/j.1365-2605.2001.00319.x
  • Reynolds-Wright, J. J., Cameron, N. J., & Anderson, R. A. (2021). Will men use novel male contraceptive methods and will women trust them? A systematic review. Journal of Sex Research, 58(7), 838–849. https://doi.org/10.1080/00224499.2021.1905764
  • Ringheim, K. (1995). Evidence for the acceptability of an injectable hormonal method for men. Family Planning Perspectives, 27(3), 123–128. https://doi.org/10.2307/2136111
  • Ringheim, K. (1996). Whither methods for men? Emerging gender issues in contraception. Reproductive Health Matters, 4(7), 79–89. https://doi.org/10.1016/S0968-8080(96)90008-7
  • Rothman, A. J., Kelly, K. M., Hertel, A. W., & Salovey, P. (2012). Message frames and illness representations: Implications for interventions to promote and sustain healthy behavior. In Taylor, &Francis (Eds.), The self-regulation of health and illness behaviour (pp. 278–296).
  • Roth, M. Y., Shih, G., Ilani, N., Wang, C., Page, S. T., & Bremner, W. J. (2014). Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial. Contraception, 90(4), 407–412. https://doi.org/10.1016/j.contraception.2014.05.013
  • Shih, G., Dubé, K., Sheinbein, M., Borrero, S., & Dehlendorf, C. (2013). He’s a real man: A qualitative study of the social context of couples’ vasectomy decisions among a racially diverse population. American Journal of Men’s Health, 7(3), 206–213. https://doi.org/10.1177/1557988312465888
  • Sjögren, B., & Gottlieb, C. (2001). Testosterone for male contraception during one year: Attitudes, well-being and quality of sex life. Contraception, 64(1), 59–65. https://doi.org/10.1016/s0010-7824(01)00223-2
  • Skogsdal, Y. R. E., Karlsson, J. Å., Cao, Y., Fadl, H. E., & Tydén, T. A. (2018). Contraceptive use and reproductive intentions among women requesting contraceptive counseling. Acta Obstetricia Et Gynecologica Scandinavica, 97(11), 1349–1357. https://doi.org/10.1111/aogs.13426
  • Study Quality Assessment Tools | National Heart, Lung, and Blood Institute (NHLBI) [Internet]. [cited. 2020 Mar 1]. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
  • Thirumalai, A., Ceponis, J., Amory, J. K., Swerdloff, R., Surampudi, V., & Liu, P. Y. (2018). Effects of 28 days of oral dimethandrolone undecanoate in healthy men: A prototype male pill. The Journal of Clinical Endocrinology and Metabolism, 104(2), 423–432. https://doi.org/10.1210/jc.2018-01452
  • Tufanaru, C., Munn, Z., Aromataris, E., Hl, C. J. Systematic reviews of effectiveness. In: E. M. Aromataris, Ed. Joanna Briggs Institute Reviewer’s Manual [Internet] The Joanna Briggs Institute; 2017 [cited. 2020 Apr 19]. Available from: https://doi.org/10.46658/JBIMES-20-04
  • van Wersch, A., Eberhardt, J., & Stringer, F. (2012). Attitudes towards the male contraceptive pill: Psychosocial and cultural explanations for delaying a marketable product. Basic and Clinical Andrology, 22(3), 171–179. https://doi.org/10.1007/s12610-012-0185-4
  • Vera Cruz, G., Humeau, A., Moore, P. J., & Mullet, E. (2019). Identifying determinants of Mozambican men’s willingness to use a male contraceptive pill. European Journal of Contraception and Reproductive Health Care, 24(4), 266–273. https://doi.org/10.1080/13625187.2019.1630816
  • Walker, S. (2011). Attitudes to a male contraceptive pill in a group of contraceptive users in the UK. Journal of Men’s Health, 8(4), 267–273. https://doi.org/10.1016/j.jomh.2011.04.003
  • Wang, C., & Swerdloff, R. S. (2010). Hormonal approaches to male contraception. Current Opinion in Urology, 20(6), 520–524. https://doi.org/10.1097/MOU.0b013e32833f1b4a
  • Weinstein, S. A., & Goebel, G. (1979). The relationship between contraceptive sex role stereotyping and attitudes toward male contraception among males. Journal of Sex Research, 15(3), 235–242. https://doi.org/10.1080/00224497909551044
  • Weston, G. C., Schlipalius, M. L., Bhuinneain, M. N., & Vollenhoven, B. J. (2002). Will Australian men use male hormonal contraception? A survey of a postpartum population. The Medical Journal of Australia, 176(5), 208–210. https://doi.org/10.5694/j.1326-5377.2002.tb04374.x
  • World Health Organization. (1982). Hormonal contraception for men: Acceptability and effects on sexuality. Studies in Family Planning, 13(11), 328–342.
  • World Health Organization. Reproductive health indicators reproductive health and research guidelines for their generation, interpretation and analysis for global monitoring. Geneva. 2006 [Internet]. [cited. 2019 Sep 2]. Available from: http://apps.who.int/iris/bitstream/handle/10665/43185/924156315X_eng.pdf;jsessionid=8461C8B1F3CCA69A48B022799A4718FA?sequence=1
  • World Health Organization, Human Reproduction Programme. Sexual health and its linkages to reproductive health: An operational approach. Geneva. 2017 [Internet]. [cited. 2019 Sep 30]. Available from: https://apps.who.int/iris/bitstream/handle/10665/258738/9789241512886-eng.pdf?sequence=1&isAllowed=y
  • Yuen, F., Nguyen, B. T., Swerdloff, R. S., & Wang, C. (2020). Continuing the search for a hormonal male contraceptive. Best Practice & Research Clinical Obstetrics & Gynaecology, 66, 83–94. https://doi.org/10.1016/j.bpobgyn.2020.02.003
  • Yuen, F., Thirumalai, A., Pham, C., Swerdloff, R. S., Anawalt, B. D., & Liu, P. Y. (2020). Daily oral administration of the novel androgen 11β-MNTDC markedly suppresses serum gonadotropins in healthy men. The Journal of Clinical Endocrinology and Metabolism, 105(3), 835–847. https://doi.org/10.1210/clinem/dgaa032
  • Zhang, L., Shah, I. H., Liu, Y., Vogelsong, K. M., & Zhang, L. (2006). The acceptability of an injectable, once-a-month male contraceptive in China. Contraception, 73(5), 548–553. https://doi.org/10.1016/j.contraception.2005.10.012

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.